{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-childhood/management/children-over-10-years-of-age/","result":{"pageContext":{"chapter":{"id":"88a19f4f-827e-5331-836f-99c46181a1f9","slug":"children-over-10-years-of-age","fullItemName":"Scenario: Children over 10 years of age","depth":2,"htmlHeader":"<!-- begin field ed3b55f5-d768-42e6-b15e-46933143b7f5 --><h2>Scenario: Childhood immunizations - over 10 years of age (including adults)</h2><!-- end field ed3b55f5-d768-42e6-b15e-46933143b7f5 -->","summary":"Covers the vaccination of healthy children from their tenth birthday onwards and young people up to the age of 25 years.","htmlStringContent":"<!-- begin item 657a54be-7c12-4360-a559-42c1f1ffc5be --><!-- begin field ca615ac5-5d55-408b-b743-acbd008874d6 --><p>From age 2 months to 25 years.</p><!-- end field ca615ac5-5d55-408b-b743-acbd008874d6 --><!-- end item 657a54be-7c12-4360-a559-42c1f1ffc5be -->","topic":{"id":"141a79f8-bf34-5bd6-9d3e-4e2d2e1c98f3","topicId":"884b0998-c242-4b76-869c-7e1d7203ac34","topicName":"Immunizations - childhood","slug":"immunizations-childhood","lastRevised":"Last revised in November 2020","chapters":[{"id":"6ba54a01-de23-5846-8b4d-e24477c75832","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8ca5ebce-3bb6-51f5-897f-9f02d913dd37","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"49b0da44-2af1-559a-aa3d-b7492cc9ee0d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"69eb6e91-b113-53eb-bd4e-6a2f49ca6593","slug":"changes","fullItemName":"Changes"},{"id":"0b393c87-257a-567c-b12f-c3d1f55b13aa","slug":"update","fullItemName":"Update"}]},{"id":"ea1bc6cb-f5cf-5581-8659-301af7d9fb67","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f586895e-7f2d-51ef-baa8-6a9a1e98695f","slug":"goals","fullItemName":"Goals"},{"id":"1420f7f8-09c4-58fa-8d52-9b4a3d2a8ddf","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"16ddc68d-be0a-56cd-b38a-9acdf13a0bfe","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"713a5cac-cd5d-58d0-8793-b453d244027d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a6ab4abc-1ddb-5864-9f72-3eb58c16089a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"b3ef6d84-ce51-57df-ba8a-40fbd3b7ceee","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e9c4eca9-e338-5ae7-9ad6-cffd74ef6c52","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"9a89a8f0-b573-5292-93a2-1ee7ba24d67e","slug":"the-routine-childhood-immunization-schedule","fullItemName":"The routine childhood immunization schedule"},{"id":"fffdcf61-8f20-593c-9fbc-a4de125dab35","slug":"childhood-immunization-programme-coverage","fullItemName":"Childhood immunization programme coverage"}]},{"id":"e9b881e0-0306-56fc-975a-71fc5731b73a","fullItemName":"Management","slug":"management","subChapters":[{"id":"75d2baa6-d689-537b-985d-3b2b1c30e8b3","slug":"children-up-to-1-year-of-age","fullItemName":"Scenario: Children up to 1 year of age"},{"id":"cb326e70-51cb-5b55-86a4-5d1f28fbcf08","slug":"children-1-2-years-of-age","fullItemName":"Scenario: Children 1-2 years of age"},{"id":"6b4cbafe-fdfb-583a-a3fe-7a96b10253c4","slug":"children-2-10-years-of-age","fullItemName":"Scenario: Children 2-10 years of age"},{"id":"88a19f4f-827e-5331-836f-99c46181a1f9","slug":"children-over-10-years-of-age","fullItemName":"Scenario: Children over 10 years of age"},{"id":"df573b46-28ae-516a-adde-90b8bc742b29","slug":"additional-immunizations","fullItemName":"Scenario: Additional immunizations"}]},{"id":"3a2ea091-53a4-51b4-8c1b-16bbc187300b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"39c5bd91-68df-5d37-bdf6-a3fbf4194d8b","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e5eea053-f5bc-5745-955b-0200236a454a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"8546e676-a44d-5c1d-a1b9-5d571b466524","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6b8c8a42-fd07-546b-8ec8-59db2829b422","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"913a73f4-d332-5491-a242-fb9e5fed1e37","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"8e7e3dc1-7bda-57e5-ba9b-f03e0049b730","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d5fbf31a-ca3a-5b16-86c7-90949cade220","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e9b881e0-0306-56fc-975a-71fc5731b73a","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"fa2ab816-cecf-55f3-aac7-a414c328f560","slug":"immunization-schedule","fullItemName":"Immunization schedule","depth":3,"htmlHeader":"<!-- begin field db1765b1-124c-4c5e-8c1d-c21407aade39 --><h3>What is the immunization schedule for children and young people from 10 years to 25 years of age?</h3><!-- end field db1765b1-124c-4c5e-8c1d-c21407aade39 -->","summary":null,"htmlStringContent":"<!-- begin item 1abc3c1e-3304-4d19-9cf9-10d91bbba18b --><!-- begin field f7ee95d6-7915-4b74-9c3c-d31620539754 --><ul><li><strong>Aged 11 years on 31 August 2020,</strong> each year from September give live attenuated influenza vaccine (LAIV — Fluenz Tetra). If LAIV is contraindicated (for example, the presence of significant immunosuppression), or the child is in a clinical risk group, use inactivated influenza vaccine.</li><li><strong>Aged 12 to 13 years,</strong> give HPV vaccine (Gardasil<sup>®</sup>). Give two doses 6–24 months apart.</li><li><strong>At fourteen years of age</strong> (school year 9), give:<ul><li>Tetanus, diphtheria, and polio vaccine (Td/IPV — Revaxis<sup>®</sup>).</li><li>Meningococcal groups A,C,W, and Y vaccine (MenACWY — Nimenrix<sup>®</sup> or Menveo<sup>®</sup>).</li></ul></li><li>There is currently a MenACWY catch-up programme in place for older adolescents and new starters at university up to the age of 25 years. See the Public Health England collection on the <a style=\"background-color: #ffffff;\" href=\"https://www.gov.uk/government/collections/meningococcal-acwy-menacwy-vaccination-programme\" data-hyperlink-id=\"51a1a89e-4945-48c3-b1d3-a8f7014c3f03\">Meningococcal ACWY vaccination programme</a> (available at www.gov.uk) for up-to-date information on eligibility.</li></ul><!-- end field f7ee95d6-7915-4b74-9c3c-d31620539754 --><!-- end item 1abc3c1e-3304-4d19-9cf9-10d91bbba18b -->","subChapters":[{"id":"40ad3c70-ba46-593b-997e-aaca280a3f69","slug":"basis-for-recommendation-565","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field de70ff95-c79f-4063-aaae-1dd3ea39b360 --><h4>Basis for recommendation</h4><!-- end field de70ff95-c79f-4063-aaae-1dd3ea39b360 -->","summary":null,"htmlStringContent":"<!-- begin item 565bb260-814b-40b7-898c-605c5151d1b4 --><!-- begin field 567dadac-490d-4738-9811-5e018dd57cfd --><p>These recommendations are based on <em>Routine childhood immunisations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016e</a>], the NHS England letter <em>The national flu immunisation programme 2020 to 2021 - update</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">NHS England, 2020</a>], and the chapter <em>The UK immunisation schedule </em>in the Public Health England (PHE) document <em>Immunisation against infectious disease</em><em> </em><em>('Green Book')</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2019b</a>].</p><ul><li>The childhood immunization schedule provides early protection for very young infants against potentially dangerous infections. Booster doses are necessary for most diseases to ensure an adequate antibody response and protection throughout childhood and into adulthood [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2014d</a>].</li></ul><h5>Meningococcal groups A,C,W, and Y catch-up programme</h5><ul><li>This recommendation is based on the PHE document<em> Introduction of a meningococcal ACWY immunisation programme for adolescents</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015l</a>].</li></ul><!-- end field 567dadac-490d-4738-9811-5e018dd57cfd --><!-- end item 565bb260-814b-40b7-898c-605c5151d1b4 -->","subChapters":[]}]},{"id":"52d0fe24-1d65-5e95-827b-10480a428b34","slug":"giving-advice","fullItemName":"Giving advice","depth":3,"htmlHeader":"<!-- begin field fb8f0889-796c-4ae4-ba4d-dd35a3874083 --><h3>What advice should I give to children and young people from 10 years to 25 years of age?</h3><!-- end field fb8f0889-796c-4ae4-ba4d-dd35a3874083 -->","summary":null,"htmlStringContent":"<!-- begin item b396a40c-3d58-445f-b705-13da23765bc4 --><!-- begin field 3d9a9c4d-0b23-467c-8617-c53b18350d40 --><ul><li><strong>Explain the benefits of vaccination,</strong> in particular that it helps prevent serious illness such as tetanus and meningococcal disease.<ul><li>Information about <a href=\"https://www.nhs.uk/conditions/vaccinations/\" data-hyperlink-id=\"f02aa51b-3772-48bc-827a-aa5600ce6d0f\">vaccinations</a> (including the UK childhood immunization schedule, vaccine safety, risks and benefits, and individual vaccines) is available on the <a href=\"https://www.nhs.uk/conditions/\" data-hyperlink-id=\"6002d8ba-0c4e-4c87-9148-aa5600ce6d23\">NHS</a> website.</li><li>A <a data-hyperlink-id=\"12761521-5ee6-475c-8e4c-a8f7014b6ac3\" href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/545554/PHE_9909_MenACWY_leaflet.pdf\">leaflet</a> is available for university entrants to explain about meningococcal disease and the importance of the MenACWY vaccine. </li></ul></li><li><strong>Reassure that vaccinations are safe, and serious adverse effects are very rare.</strong> Pain, swelling, and reddening at the site of injection are most common and systemic effects, should they occur, are usually limited to mild fever.</li><li><strong>Advise that people with egg allergy</strong> can be given the measles, mumps, and rubella (MMR) vaccination. However, people with egg allergy may be at increased risk of having a reaction to some influenza vaccines. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-seasonal-influenza/\">Immunizations - seasonal influenza</a>.</li><li><strong>Advise the person or their parents not to give paracetamol or ibuprofen to prevent fever around the time of vaccination.</strong> However if pain or fever is problematic <em>after</em> vaccination then paracetamol or ibuprofen may be used. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a>.</li></ul><!-- end field 3d9a9c4d-0b23-467c-8617-c53b18350d40 --><!-- end item b396a40c-3d58-445f-b705-13da23765bc4 -->","subChapters":[{"id":"daf2faa4-3bb7-5ac0-9f25-41f0cb085e85","slug":"basis-for-recommendation-196","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field d14e5ce6-0ec7-4d2a-ba6a-21ac690c158c --><h4>Basis for recommendation</h4><!-- end field d14e5ce6-0ec7-4d2a-ba6a-21ac690c158c -->","summary":null,"htmlStringContent":"<!-- begin item 196033ad-a60e-4a0d-9193-893693395649 --><!-- begin field e98feceb-31d5-44e6-a93d-73f07acb7ed6 --><p>The recommendations on advice to give to parents and carers are based on information in the chapter on vaccine safety and adverse effects following immunization in <em>Immunisation against infectious disease</em> (the 'Green Book'), published by Public Health England (PHE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013l</a>], and are pragmatic, based on what CKS considers to be good clinical practice.</p><h5>Advice for people with egg allergy</h5><ul><li>This recommendation is based on information in the chapter on contraindications and special considerations in <em>Immunisation against infectious disease</em> (the 'Green Book') [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013o</a>].</li></ul><h5>Using paracetamol or ibuprofen</h5><ul><li>CKS found no controlled trials on the efficacy of paracetamol or ibuprofen in reducing pain or fever following vaccination.<ul><li>As paracetamol and ibuprofen have been shown to reduce fever and pain in conditions such as the common cold and influenza [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">Eccles, 2006</a>], it can be reasonably extrapolated that they may be effective in relieving these symptoms on an 'as required' basis after vaccination.</li></ul></li><li>PHE recommends that paracetamol or ibuprofen should not be given to <em>prevent</em> fever in children who receive vaccinations [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013l</a>]. It states that there is no evidence that paracetamol or ibuprofen prevent febrile convulsions and that there is some evidence that they may lower antibody responses to some vaccines when given around the time of vaccination [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">Prymula et al, 2009</a>].</li></ul><!-- end field e98feceb-31d5-44e6-a93d-73f07acb7ed6 --><!-- end item 196033ad-a60e-4a0d-9193-893693395649 -->","subChapters":[]}]},{"id":"ff33a90d-c8c7-5a98-b718-c011c704b5e6","slug":"missed-doses","fullItemName":"Missed doses","depth":3,"htmlHeader":"<!-- begin field a0211d2e-5fbc-4650-8f0b-d6e97c7da028 --><h3>What should I do if a child or young person from 10 years to 25 years of age has missed doses?</h3><!-- end field a0211d2e-5fbc-4650-8f0b-d6e97c7da028 -->","summary":null,"htmlStringContent":"<!-- begin item 4e966252-d931-44ff-a22c-b31e66c8ceb6 --><!-- begin field 72041352-4916-4a3b-a864-28cbcced2de3 --><p><strong>After 10 years of age, not all vaccinations are necessary, as the period of risk from some childhood diseases will have passed. </strong><strong>Doses already given do not need to be repeated,</strong> that is, primary immunization should be continued, not restarted.Missed dose of diphtheria, tetanus, pertussis, poliomyelitis, and <em>Haemophilus influenzae</em> type b (Hib) vaccine (DTaP/IPV/Hib) — complete the primary course (total of three doses) by substituting DTaP/IPV/Hib with tetanus, diphtheria, and polio (Td/IPV), spaced 4 weeks apart. A further two booster doses of Td/IPV will then be required, one dose 5 years after completing the primary course, followed by another dose after ideally a further 10 years (minimum of 5 years).</p><ul><li>Missed dose of diphtheria, tetanus, pertussis, poliomyelitis booster vaccine (DTaP/IPV) — give a dose of Td/IPV five years after completing the primary course, followed by another dose of Td/IPV after ideally a further 10 years (minimum of 5 years).</li><li>Missed pneumococcal conjugate vaccine (PCV) — no vaccine required unless the person is at high risk. For more information, see the <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-childhood/management/additional-immunizations/\">Scenario: Additional childhood immunizations</a> and the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-pneumococcal/\">Immunizations - pneumococcal</a>.</li><li>Missed meningococcal group C (MenC) or MenACWY vaccine:<ul><li>Give a single dose of MenACWY to all people 10–25 years of age who have never received a MenC-containing vaccine. </li><li>If the person has previously received a MenC vaccine, see the Public Health England (PHE) information on the <a href=\"https://www.gov.uk/government/collections/meningococcal-acwy-menacwy-vaccination-programme\" data-hyperlink-id=\"9f7555fa-bcf0-4770-ae8e-a8f7015cfa9b\">MenACWY vaccination programme</a> as they may be eligible for a vaccination under the current catch-up scheme.</li></ul></li><li>Missed measles, mumps, and rubella vaccine (MMR) — ensure the person has had two doses in total, spaced at least 4 weeks apart. </li><li>Missed human papillomavirus (HPV — Gardasil®) vaccine. If a dose has been missed — resume, but do not repeat doses, ideally leaving an appropriate interval between the remaining doses.<ul><li>Girls who have not had their first dose of HPV vaccine by the time they are 15 years old should be offered the three-dose schedule given at 0, 1, and 4–6 months (instead of the two-dose schedule).<ul><li>A three-dose course started but not completed before a girl's eighteenth birthday should be completed, leaving a 3-month interval between the second and third doses (a minimum of one month if the course is unlikely to be completed otherwise).</li></ul></li><li>Girls who commenced the HPV vaccine course before the age of 15 years should be offered the two-dose schedule given at 0 and 6–24 months.<ul><li>Give the second dose even if it is more than 24 months since the first dose or the girl is 15 years of age or older.</li></ul></li><li>If a three-dose course was started at younger than 15 years of age, before September 2014, and:<ul><li>One dose has been given — complete a two-dose course by giving a second dose 6–24 months later.</li><li>Two doses have been given less than 6 months apart — give a third dose at least three months after the second dose.</li></ul></li></ul></li><li><strong>For the latest information about catch-up recommendations,</strong> see the PHE <a href=\"https://www.gov.uk/government/collections/immunisation\" data-hyperlink-id=\"ba5ded1b-4b9b-460e-a060-a8f7015cface\">information for immunisation practitioners and other health professionals</a>, available at www.gov.uk. </li><li><strong>For an algorithm outlining the requirements for people who have missed vaccination doses,</strong> see the PHE document <a href=\"https://www.gov.uk/government/publications/vaccination-of-individuals-with-uncertain-or-incomplete-immunisation-status\" data-hyperlink-id=\"c762bc99-1965-482f-8f44-a8f7015cfb2d\">Vaccination of individuals with uncertain or incomplete immunisation status</a>.</li></ul><!-- end field 72041352-4916-4a3b-a864-28cbcced2de3 --><!-- end item 4e966252-d931-44ff-a22c-b31e66c8ceb6 -->","subChapters":[{"id":"1da48138-753b-5c4d-9048-bb3c953e56a7","slug":"basis-for-recommendation-443","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field c88c4f9e-63cb-447a-80bb-29b414def74f --><h4>Basis for recommendation</h4><!-- end field c88c4f9e-63cb-447a-80bb-29b414def74f -->","summary":null,"htmlStringContent":"<!-- begin item 443ed114-f7c4-49a7-8531-7c2a50445350 --><!-- begin field 1298b470-e29a-4605-9888-5fee20446545 --><p>These recommendations are based on <em>Routine childhood immunisations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016e</a>], <em>The routine immunisation schedule</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016g</a>], and <em>Vaccination of individuals with uncertain or incomplete immunisation status </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2016h</a>], published by Public Health England (PHE).</p><ul><li>In the chapter entitled <em>The UK immunisation schedule</em>, the 'Green Book' states that 'if any course of immunisation is interrupted, it should be resumed and completed as soon as possible. There is generally no need to start any course of immunisation again' [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2014d</a>].</li></ul><h5>Meningococcal groups A,C,W, and Y (MenACWY) catch-up scheme</h5><ul><li>The information on MenACWY vaccination is also based on the PHE document <em>Introduction of a meningococcal ACWY immunisation programme for adolescents</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015l</a>].</li></ul><!-- end field 1298b470-e29a-4605-9888-5fee20446545 --><!-- end item 443ed114-f7c4-49a7-8531-7c2a50445350 -->","subChapters":[]}]},{"id":"8a793ad7-cda4-5a79-940d-2b2f3e5e1615","slug":"unknown-immunization-history","fullItemName":"Unknown immunization history","depth":3,"htmlHeader":"<!-- begin field 1bcbf0fd-b4d6-442c-b4c9-0903fe4b0ade --><h3>What should I do if a child or young person from 10 years to 25 years of age has not been immunized or has an unknown immunization status?</h3><!-- end field 1bcbf0fd-b4d6-442c-b4c9-0903fe4b0ade -->","summary":null,"htmlStringContent":"<!-- begin item 4a8e4713-604d-470c-9d47-9e44d5d525e7 --><!-- begin field 81ca6f23-f3b7-4f9b-86cd-c543bd717080 --><ul><li><strong>Plan to provide catch-up vaccinations to ensure protection quickly</strong> (with the minimum number of visits in the shortest possible timescale).</li><li><strong>If the person presents without a reliable immunization history, attempt to clarify what vaccines they have had wherever possible.</strong><ul><li>People born outside the UK may have received some or all of the vaccinations that would be expected in the UK. For further information, see the <a href=\"http://apps.who.int/immunization_monitoring/globalsummary\" style=\"background-color: rgb(255, 255, 255);\" data-hyperlink-id=\"426e18ec-b77c-4f39-95ba-a8f7014c492d\">country by country guide to immunization</a> from the World Health Organization.</li></ul></li><li><strong>If the history cannot be clarified, assume that the person has not been vaccinated.</strong> Give the following vaccinations:<ul><li>Three doses of diphtheria, tetanus, poliomyelitis vaccine (Td/IPV), spaced 4 weeks apart. </li><li>Two doses of measles, mumps, and rubella (MMR) vaccine, spaced at least 4 weeks apart.</li><li>One dose of meningococcal groups A,C,W, and Y vaccine (Men ACWY) to people aged 10–25 years who have never received a MenC-containing vaccine.</li><li>Human papillomavirus (HPV — Gardasil®) vaccine, for girls from 12 years of age up to their 18th birthday:<ul><li>For girls under 15 years of age, give a two-dose course at 0 and 6–24 months.</li><li>For girls aged 15 years and over, give a three-dose course at 0, 1, and 4–6 months.</li></ul></li></ul></li><li><strong>Two additional booster doses</strong> of Td/IPV are required, the first 5 years after the primary course is completed and the second ideally ten years (a minimum of five years) after the first booster.</li><li><strong>For an algorithm outlining the requirements for people who have not been immunized or have an unknown immunization status, </strong>see the Public Health England document <a href=\"https://www.gov.uk/government/publications/vaccination-of-individuals-with-uncertain-or-incomplete-immunisation-status\" data-hyperlink-id=\"bf144d7a-4a85-4747-bcc3-a8f7014c4949\">Vaccination of individuals with uncertain or incomplete immunisation status</a>.</li></ul><!-- end field 81ca6f23-f3b7-4f9b-86cd-c543bd717080 --><!-- end item 4a8e4713-604d-470c-9d47-9e44d5d525e7 -->","subChapters":[{"id":"847daef5-d8a2-545e-ba09-dfb03c9af7e6","slug":"basis-for-recommendation-4b7","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2e2e0281-814e-44e8-a9d4-0856605a594b --><h4>Basis for recommendation</h4><!-- end field 2e2e0281-814e-44e8-a9d4-0856605a594b -->","summary":null,"htmlStringContent":"<!-- begin item 4b7d840f-1dbf-4d7c-a700-b94e5530c93d --><!-- begin field 62cca41c-ea9c-422b-94a4-5ed305ec4313 --><p>These recommendations are based on the chapter on the UK immunization schedule in <em>Immunisation against infectious disease </em>(the 'Green Book') [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2014d</a>] and the guideline <em>Vaccination of individuals with uncertain or incomplete immunisation status</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2015k</a>], published by Public Health England.</p><!-- end field 62cca41c-ea9c-422b-94a4-5ed305ec4313 --><!-- end item 4b7d840f-1dbf-4d7c-a700-b94e5530c93d -->","subChapters":[]}]},{"id":"01376314-0695-5093-ae0a-3213a4a21097","slug":"administering-the-vaccine","fullItemName":"Administering the vaccine","depth":3,"htmlHeader":"<!-- begin field f5065374-2b25-4fd6-be89-ed6377597201 --><h3>How should I administer vaccines in a child or young person from 10 years to 25 years of age?</h3><!-- end field f5065374-2b25-4fd6-be89-ed6377597201 -->","summary":null,"htmlStringContent":"<!-- begin item b66daf58-08dd-43d9-bb82-bc70864db0cc --><!-- begin field f142d5d7-9c1a-4e35-af5a-10b241daab75 --><ul><li><strong>Obtain written or verbal consent at the time of vaccination</strong> for people aged over 16 years. For younger people it is usual to get consent from a person with parental responsibility.<ul><li>Adults over 18 years of age are presumed to be competent to consent to treatment provided they can comprehend and retain the information they are given, they believe it, and they can consider the facts and make an informed decision.</li><li>Young people of 16 and 17 years of age are also presumed to be competent using the same criteria as older adults.</li><li>Younger people can also give consent if they fully understand what is involved, but ideally a person with parental responsibility should also be involved.</li></ul></li><li><strong>Ensure that: </strong><ul><li>There are no contraindications to the vaccine (for example, the presence of significant immunosuppression before administering live attenuated vaccines).</li><li>The person, parent, or carer has been <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-childhood/management/children-over-10-years-of-age/#giving-advice\">fully informed</a> about the vaccine and the vaccination procedure.</li><li>Possible adverse reactions have been discussed and the person, parent, or carer is aware of how to manage them.<strong> </strong></li></ul></li><li><strong>Check that the vaccine is correct, has been stored appropriately, and has not expired. </strong></li><li><strong>When administering the vaccine:</strong><ul><li>Wash the site with soap and water if it is visibly dirty. </li><li>Most vaccines are given by intramuscular (IM) injection. If the person has a bleeding disorder, use the subcutaneous (SC) route for vaccines normally given by the IM route as this reduces the risk of bleeding. <ul><li>Use a 25 mm 23-gauge (blue) or 25-gauge (orange) needle for IM administration. </li><li>Give IM and SC immunizations into the anterolateral aspect of the thigh or the deltoid area of the upper arm. If an additional vaccine is required on the same day, use separate limbs if possible, or inject at sites at least 2.5 cm apart. </li><li>Do not give immunizations into the buttock. </li></ul></li><li>Record the date of administration, vaccine and product name, batch number, expiry date, dose administered, and site of administration for each vaccine. </li></ul></li><li><strong>Observe the person after vaccination</strong> to detect immediate adverse reactions. Ensure any bleeding has stopped and check for any symptoms of anaphylaxis before they leave.<ul><li>Anaphylaxis is extremely rare, and usually becomes apparent within minutes. By the time the site has been checked for bleeding and documentation has been completed, most reactions will have become apparent. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul></li></ul><!-- end field f142d5d7-9c1a-4e35-af5a-10b241daab75 --><!-- end item b66daf58-08dd-43d9-bb82-bc70864db0cc -->","subChapters":[{"id":"d97857ab-d885-5823-b114-b572a0064641","slug":"basis-for-recommendation-851","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e3e0669e-7df4-4c4f-84c3-80da0f60417f --><h4>Basis for recommendation</h4><!-- end field e3e0669e-7df4-4c4f-84c3-80da0f60417f -->","summary":null,"htmlStringContent":"<!-- begin item 8515aef4-0363-4995-b751-447b6677edd7 --><!-- begin field 9129534d-750c-4d84-8d4e-992dd268e6b7 --><p>These recommendations are based on chapters in <em>Immunisation against infectious disease</em> (the 'Green Book'), published by Public Health England [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013m</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013n</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013l</a>], and what CKS considers to be good clinical practice.</p><h5>Consent</h5><ul><li>Consent for immunizations does not legally have to be in writing, but must be given voluntarily by a fully informed person who is able to make and communicate their decision. For children not competent to give or withhold consent, a person with parental responsibility can provide this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013m</a>]. </li><li>The information regarding consent in young people 16–17 years of age and children younger than 16 years of age is based on the <em>Reference guide to consent for examination or treatment</em> from the Department of Health [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">DH, 2009</a>].</li></ul><h5>Site of administration</h5><ul><li>The site of administration depends on the person's age [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-childhood/references/\">PHE, 2013n</a>]: <ul><li>The deltoid muscle or the anterior aspect of the thigh can be used for administration. However, the deltoid muscle is generally preferred for most people as it is convenient, providing easy access. </li><li>The gluteal muscle should be avoided. The needle may not penetrate through adipose tissue into the muscle, and this may cause a poor immunological response to the vaccine. In addition, there is a risk of damage to underlying structures such as the sciatic nerve.</li></ul></li></ul><!-- end field 9129534d-750c-4d84-8d4e-992dd268e6b7 --><!-- end item 8515aef4-0363-4995-b751-447b6677edd7 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}